. 2018 Dec 26;23(1):1–20. doi: 10.4196/kjpp.2019.23.1.1
Copyright © Korean J Physiol Pharmacol
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 1. Summarized findings related to new targets in neuropathic pain.
